
Jennifer Litton
658 posts

Jennifer Litton
@JenniferLitton
Breast Medical Oncologist at MDAnderson. Vice President Clinical Research. Tweets and opinions are my own.



Interesting move in the new NCCN guidelines: ADCs are now listed as a first-line option in mTNBC, even before FDA approval. Highlights how rapidly the treatment landscape is evolving. #sabcs25 @ASCO @SABCSSanAntonio #MedTwitter @OncBrothers @TotalHealthConf @PTarantinoMD @drsarahsam




















Again, not all confirmed, just names heard, pls add/confirm in or out: 1. Sylvester Turner 2. Jolanda Jones 3. Jarvis Johnson 4. Chris Hollins 5. Amanda Edwards 6. Christian Menefee 7. Danny Norris 8. Bishop Dixon 9. Dwight Boykins 10. Armando Walle 11. Leticia Plummer



“ADRIATIC is the first positive global Phase III trial of immunotherapy for limited stage small cell #LungCancer,” says our Dr. @LaurenByersMD at #ASCO24. “This groundbreaking trial sets a new standard of care with consolidative durvalumab following concurrent chemoradiotherapy.” @ASCO #EndCancer



The antibody drug conjugate M9140 demonstrates promising activity in heavily pretreated patients with advanced #ColorectalCancer. Read about the findings presented by our Dr. Scott Kopetz (Abstract 3000) at #ASCO24: bit.ly/4bHkgzc @skopetz @ASCO #EndCancer

Congratulations to @KellyKhunt on your induction into @OncLive's 12th Annual Giants of Cancer Care recognition program! Recognizing your contributions to breast cancer research and patient care @MDAndersonNews #OncSurgery #EndCancer



